Results 251 to 260 of about 47,007 (284)

[Osteoprotegerin (OPG)].

Nihon rinsho. Japanese journal of clinical medicine, 2011
Naoki, Takahashi, Hideki, Kimura, Kenji, Kasuno, Haruyoshi, Yoshida, Junichiro James, Kazama   +4 more
openaire   +1 more source

Functions of RANKL/RANK/OPG in bone modeling and remodeling

Archives of Biochemistry and Biophysics, 2008
Brendan F Boyce, Lianping Xing
exaly  

High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-κB ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis

Clinical Biochemistry, 2008
Ioannis Papassotiriou, Smaragdi Fessatou, Evangelos Terpos   +2 more
exaly  

[OPG, anti-rANKL antibody].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Identification of RANKL/ODF (receptor activator of NF-kappaB ligand/osteoclast differentiation factor), RANK(receptor activator of NF-kappaB) and OPG/OCIF(osteoprotegerin/ osteoclastogenesis inhibitory factor) revealed the mechanisms regulating osteoclast differentiation and function.
openaire   +1 more source

Serum Levels of OPG, RANKL, and RANKL/OPG Ratio in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-analysis

Immunological Investigations, 2019
Mengya Chen, Xingxing Hu, Renfang Han
exaly  

RANKL/RANK/OPG system and bone status in females with anorexia nervosa

Bone, 2012
Zofia Ostrowska, Katarzyna Ziora, Elż̇Bieta Świętochowska   +2 more
exaly  

Osteoclast differentiation by RANKL and OPG signaling pathways

Journal of Bone and Mineral Metabolism, 2020
Nobuyuki Udagawa, Masanori Koide, Midori Nakamura   +2 more
exaly  

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers

EBioMedicine, 2015
Martin Widschwendter, Lindsay Fraser, Daniel Reisel   +2 more
exaly  

OPG/membranous–RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation

Bone, 2006
Steeve Kwan Tat, Marc Padrines, Dominique Heymann   +2 more
exaly  

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis

Biochimica Et Biophysica Acta: Reviews on Cancer, 2004
S Théoleyre, Frédéric Blanchard, Dominique Heymann   +2 more
exaly